Dashboard
Manage Tickers

ALCALCON INC

NYSE alcon.com


$ 78.85 $ -0.72 (-0.9 %)    

Thursday, 25-Apr-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 430.17 $ 9.15 (2.17 %)
DIA $ 380.88 $ -3.52 (-0.92 %)
SPY $ 507.81 $ 5.55 (1.11 %)
TLT $ 87.78 $ -0.61 (-0.69 %)
GLD $ 215.92 $ 1.27 (0.59 %)
$ 78.84
$ 78.47
$ 0.00 x 0
$ 78.86 x 100
$ 78.04 - $ 78.97
$ 69.44 - $ 88.23
853,714
na
39.25B
$ 0.90
$ 40.30
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stifel-maintains-buy-on-alcon-maintains-95-price-target
Stifel Maintains Buy on Alcon, Maintains $...
04/22/2024 17:36:39

Stifel analyst Thomas Stephan maintains Alcon (NYSE:ALC) with a Buy and maintains $95 price target.

goldman-sachs-initiates-coverage-on-alcon-with-buy-rating-announces-price-target-of-100
Goldman Sachs Initiates Coverage On Alcon ...
04/10/2024 10:02:15

Goldman Sachs analyst Richard Felton initiates coverage on Alcon (NYSE:ALC) with a Buy rating and announces Price Target of ...

stifel-reiterates-buy-on-alcon-maintains-95-price-target
Stifel Reiterates Buy on Alcon, Maintains ...
03/13/2024 17:17:53

Stifel analyst Thomas Stephan reiterates Alcon (NYSE:ALC) with a Buy and maintains $95 price target.

argus-research-maintains-buy-on-alcon-raises-price-target-to-100
Argus Research Maintains Buy on Alcon, Rai...
03/04/2024 15:03:42

Argus Research analyst John Staszak maintains Alcon (NYSE:ALC) with a Buy and raises the price target from $90 to $100.

piper-sandler-maintains-buy-on-alcon-raises-price-target-to-100
Piper Sandler Maintains Buy on Alcon, Rais...
03/01/2024 14:41:59

Piper Sandler analyst Anthony Petrone maintains Alcon (NYSE:ALC) with a Buy and raises the price target from $95 to $100.

keybanc-maintains-overweight-on-alcon-raises-price-target-to-92
Keybanc Maintains Overweight on Alcon, Rai...
02/29/2024 16:33:00

Keybanc analyst Brett Fishbin maintains Alcon (NYSE:ALC) with a Overweight and raises the price target from $87 to $92.

needham-reiterates-buy-on-alcon-maintains-86-price-target
Needham Reiterates Buy on Alcon, Maintains...
02/28/2024 10:20:09

Needham analyst David Saxon reiterates Alcon (NYSE:ALC) with a Buy and maintains $86 price target.

alcon-sees-2024-core-diluted-eps-300-310-vs-304-est-net-sales-99b-101b-vs-995b-est
Alcon Sees 2024 Core Diluted EPS $3.00-$3....
02/27/2024 22:55:19

alcon-q4-2023-adj-eps-070-beats-067-estimate-sales-233b-miss-234b-estimate
Alcon Q4 2023 Adj EPS $0.70 Beats $0.67 Es...
02/27/2024 22:54:16

Alcon (NYSE:ALC) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.67 by 4.48 perc...

earnings-preview-what-to-expect-to-when-eye-health-company-bausch--lomb-reports-q4-performance-later-this-month
Earnings Preview: What To Expect To When E...
02/09/2024 19:24:44

"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital pr...

keybanc-initiates-coverage-on-alcon-with-overweight-rating-announces-price-target-of-87
Keybanc Initiates Coverage On Alcon with O...
02/06/2024 11:50:35

Keybanc analyst Brett Fishbin initiates coverage on Alcon (NYSE:ALC) with a Overweight rating and announces Price Target of ...

baird-reiterates-outperform-on-alcon-maintains-94-price-target
Baird Reiterates Outperform on Alcon, Main...
01/30/2024 18:36:27

Baird analyst Jeff Johnson reiterates Alcon (NYSE:ALC) with a Outperform and maintains $94 price target.

buy-this-ophthalmology-stock-but-sell-this-one-says-bernstein-analyst-innovation-is-key
Buy This Ophthalmology Stock But Sell This...
01/23/2024 17:47:03

Innovation and digitalization have been in focus among ophthalmology majors.

bernstein-initiates-coverage-on-alcon-with-outperform-rating-announces-price-target-of-944
Bernstein Initiates Coverage On Alcon with...
01/23/2024 11:53:10

Bernstein analyst Susannah Ludwig initiates coverage on Alcon (NYSE:ALC) with a Outperform rating and announces Price Target...

good-news-for-dry-eye-disease-patients-eye-care-focused-alcons-treatment-shows-encouraging-benefit-in-late-stage-trials
Good News For Dry Eye Disease Patients: Ey...
01/10/2024 11:53:50

Alcon (NYSE: ALC) released topline results from the two Phase 3 trials (COMET-2 and COMET-3) evaluating the efficacy and safety...

alcon-announces-topline-results-from-phase-3-comet-trials-of-ar-15512-in-both-pivotal-efficacy-and-safety-studies-primary-endpoint-was-achieved
Alcon Announces Topline Results From Phase...
01/09/2024 21:35:24

Core News & Articles
Lifecore Biomedical Announced That It Has ...
01/05/2024 13:06:58

Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements Lifecore re...

stifel-initiates-coverage-on-alcon-with-buy-rating-announces-price-target-of-85
Stifel Initiates Coverage On Alcon with Bu...
12/12/2023 09:17:56

Stifel analyst Thomas Stephan initiates coverage on Alcon (NYSE:ALC) with a Buy rating and announces Price Target of $85.

argus-research-maintains-buy-on-alcon-lowers-price-target-to-90
Argus Research Maintains Buy on Alcon, Low...
12/06/2023 16:05:08

Argus Research analyst John Staszak maintains Alcon (NYSE:ALC) with a Buy and lowers the price target from $95 to $90.

what-6-analyst-ratings-have-to-say-about-alcon
What 6 Analyst Ratings Have To Say About A...
12/04/2023 12:00:39

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION